TLR9 ligand trap
US-11976104-B2 · May 7, 2024 · US
This page is not indexed by search engines while we improve data quality.
Wei Sheng patents
Wei Sheng is listed as an inventor on 49 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wei Sheng |
| Total patents | 49 |
| First publication | Jan 29, 2015 |
| Latest publication | May 7, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Soluble cd33 for treating myelodysplastic syndromes (mds)
US-2023348555-A1 · Nov 2, 2023 · US
System and method for low-latency content streaming
US-11622134-B2 · Apr 4, 2023 · US
Soluble CD33 for treating myelodysplastic syndromes (MDS)
US-11584787-B2 · Feb 21, 2023 · US
Chimeric tim-3 fusion protein
US-2022144897-A1 · May 12, 2022 · US
TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
US-2022143193-A1 · May 12, 2022 · US
TLR9-binding chimeric antigen receptors
US-11286306-B2 · Mar 29, 2022 · US
PD1 and PDL-1 expression during progression from myelodysplastic syndrome to acute myelogenous leukemia
US-11287428-B2 · Mar 29, 2022 · US
Chimeric antigen receptors with enhanced tumor infiltration
US-2022088073-A1 · Mar 24, 2022 · US
Tlr9-targeted therapeutics
US-2022041682-A1 · Feb 10, 2022 · US
Recent patents
Latest publications not already listed above.
TLR9 targeted therapeutics
US-11123435-B2 · Sep 21, 2021 · US
System and Method for Low-Latency Content Streaming
US-2021289235-A1 · Sep 16, 2021 · US
Tlr9 ligand trap
US-2021253664-A1 · Aug 19, 2021 · US
Pd1 and pdl-1 expression during progression from myelodysplastic syndrome to acute myelogenous leukemia
US-2021239703-A1 · Aug 5, 2021 · US
System and method for low-latency content streaming
US-11025962-B2 · Jun 1, 2021 · US
Streaming media segments
US-2021067578-A1 · Mar 4, 2021 · US
Chimeric tim-3 fusion protein
US-2021024582-A1 · Jan 28, 2021 · US
Reducing requests for media segments in streaming of multimedia content
US-10880357-B2 · Dec 29, 2020 · US
Tetravalent tlr9 bispecific antibody
US-2020354471-A1 · Nov 12, 2020 · US
Icariin derivatives
US-2020354331-A1 · Nov 12, 2020 · US
Inflammasome activation in myelodysplastic syndromes
US-10688077-B2 · Jun 23, 2020 · US
Targeted sensitization of non-del(5q) malignant cells
US-10682417-B2 · Jun 16, 2020 · US
Icariin and icaritin derivatives
US-2020115358-A1 · Apr 16, 2020 · US
Soluble cd33 for treating myelodysplastic syndromes (mds)
US-2020055916-A1 · Feb 20, 2020 · US
Tlr9-binding chimeric antigen receptors
US-2019309086-A1 · Oct 10, 2019 · US
Soluble CD33 for treating myelodysplastic syndromes (MDS)
US-10344072-B2 · Jul 9, 2019 · US
Tlr9 targeted therapeutics
US-2019192669-A1 · Jun 27, 2019 · US
Tlr9 targeted cytotoxic agents
US-2019167803-A1 · Jun 6, 2019 · US
TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
US-2018369396-A1 · Dec 27, 2018 · US
Power efficient multimedia content streaming based on a server push
US-10158682-B2 · Dec 18, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| H Lee Moffitt Cancer Ct & Res | 31 |
| Adobe Systems Inc | 14 |
| Adobe Inc | 5 |
| Anp Tech Inc | 1 |
| Swaminathan Viswanathan | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 21 |
| A61K38/00 | 12 |
| H04L67/02 | 12 |
| C07K14/70596 | 11 |
| C12N2310/14 | 10 |